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INTRODUCTION
The formation of a properly functioning epidermal barrier is a 
prerequisite for terrestrial life. The epidermis not only protects 
from external influences such as pathogens, chemicals, and 
UV light, but also prevents dehydration. To maintain proper 
barrier function, the epidermis undergoes a dynamic turn-
over driven by proliferating keratinocytes in the basal layer 
that, upon induction of differentiation, will move upward 
through the stratum spinosum and stratum granulosum while 
undergoing a terminal differentiation process to ultimately 
form the stratum corneum (SC). This layer is in direct con-
tact with the outside environment and provides important 
structural and innate immune barrier properties. Barrier func-
tion is initiated when stratum granulosum keratinocytes start 
secreting and crosslinking specific proteins and lipids into 
the intercellular space and at the same time transform their 
membrane into a so-called cornified envelope (e.g., by link-
ing different structural proteins such as loricrin to the inner 
side of the cell membrane). Consequently, keratinocytes shed 
their nucleus to become corneocytes forming the SC.
In recent years it has become clear that the SC is not the 
sole structure providing barrier properties to the epidermis. 
It is now clear that specialized intercellular junctions, called 
tight junctions (TJs), are present between cells of the granular 
layer, where they ensure proper barrier function (Furuse et 
al., 2002; Tunggal et al., 2005). TJs have been well character-
ized in simple epithelia where they form a paracellular size- 
and ion-specific barrier to separate tissue compartments. The 
size and ion selectivity of TJs is mainly based on which mem-
bers of the claudin family of transmembrane proteins are 
located in the TJs of different tissues. The epidermis expresses 
several claudins, and loss of claudin-1 in mice results in peri-
natal lethality attributable to rapid dehydration (Furuse et al., 
2002). In addition, TJs are crucial for immune surveillance by 
Langerhans cells (Kubo et al., 2009).
The importance of the two barriers is further confirmed by 
observations that mutations in SC proteins such as filaggrin 
are linked to diseases characterized by an impaired skin bar-
rier, such as atopic dermatitis and ichthyosis vulgaris (Palmer 
et al., 2006; Smith et al., 2006). In addition, human clau-
din-1 mutations are associated with neonatal sclerosing chol-
angitis associated with ichthyosis (Hadj-Rabia et al., 2004). 
However, the exact molecular mechanisms of how TJs and 
the SC contribute to the formation, maintenance, and resto-
ration of the skin barrier are not well understood. In addition, 
it is not known whether and how TJs and the SC cooperate to 
form a fully functional skin barrier.
Transgenic mouse models have been helpful tools to 
investigate how proteins implicated in epidermal barrier 
function contribute to the formation and maintenance of skin 
barrier function. Next to assessing whether such mice have a 
BENEFITS OF DYE PENETRATION ASSAYS
•  Dye penetration assays are a powerful tool to assess 
potential leakiness of the epidermal barrier in vivo.
•  A combination of different assays provides an 
indication about the functionality of both the 
stratum corneum and the tight junction barrier.
•  Application of different molecules can point to the 
nature of a barrier defect.
LIMITATIONS
•  Dye penetration assays do not provide a molecular 
explanation for a barrier defect.
•  Application of a single method may not display the 
exact origin of a barrier defect.
•  Tight junction penetration assays are often difficult 
to evaluate in adult mice because their stratum 
granulosum is hardly visible.
•  The functional threshold of the assays and the 
physiological barrier may differ.
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ous occludin-based TJs in the granular layer. They found 
that loss of claudin-1 increased transepidermal water loss, 
leading to perinatal death in claudin-1-deficient mice 
accompanied by biotin leakage above the granular layer, 
highlighting the importance of TJs for epidermal water bar-
rier function (Furuse et al., 2002). The assay was also used to 
provide evidence that epidermal deletion of the adher-
ens junction protein E-cadherin impaired TJs, resulting in 
a phenotype strikingly similar to that of the claudin-1 mice 
(Tunggal et al., 2005). The assay also demonstrated that TJs 
function as an intercellular permeability barrier to small mol-
ecules (~550 Da) in human epidermis (Yuki et al., 2011).
To test the TJ barrier in mice, 10 mg/ml EZ-Link sulfo-
NHS-LC-biotin (Pierce Chemical Co., Rockford, IL) in phos-
phate-buffered saline containing 1 mM CaCl2 is injected 
intradermally into the back skin of newborn mice. After 
30 minutes of incubation, mice are sacrificed and the skin 
is isolated and embedded in Tissue-Tek and snap-frozen 
in liquid nitrogen. Paraformaldehyde-fixed cryosections 
are stained with an appropriate primary antibody that rec-
ognizes a TJ protein to mark these junctions in the granu-
lar layer (frequently used targets are zonula occludens-1 
or occludin). After being washed with phosphate-buffered 
saline (PBS), sections are incubated with an appropriate 
fluorescent-labeled secondary antibody to label TJs, in com-
bination with a different fluorescent-labeled streptavidin to 
follow penetration of biotin and 4′,6-diamidino-2-phenylin-
dole to label nuclei. After repeated washings with PBS, sec-
dysfunctional skin barrier as measured by, for example, trans-
epidermal water loss, it would be important to assess their 
SC and TJ barrier function. To this end, different dye penetra-
tion assays have been developed to determine a potential SC 
or TJ barrier defect in these mouse models. These assays can 
be subdivided into assays that use dyes to assess either the 
outside-in or the inside-out penetration to analyze SC and 
TJ permeability, respectively. Dye diffusion assays provide 
a rapid and relatively cost-effective tool to assess epidermal 
barrier function. Note that diffusion of each of the described 
dyes through a barrier was shown to correlate with a physi-
ological dysfunction of the respective barrier; however, the 
threshold of a barrier for being permeable for a dye or physi-
ological solutes or water can differ.
INSIDE-OUT TIghT jUNCTION BARRIER ASSAY: BIOTIN 
DIFFUSION
The functionality of the TJ barrier can be tested using tracer 
molecules of different sizes that cannot pass a properly func-
tioning TJ barrier. Sulfo-NHS-esters of biotin will efficiently 
label proteins by binding primary amine-containing macro-
molecules on the cell surface. Once injected into the dermis, 
biotin reagents will diffuse through the intercellular space 
but will not pass a functional TJ barrier in the granular layer. 
Thus, diffusion of biotin above the stratum granulosum indi-
cates a disrupted TJ barrier (Figure 1).
Furuse et al. (2002) were the first to successfully use this 
method to provide evidence for the presence of continu-
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Figure 1.  Inside-out barrier: biotin diffusion assay. (a) In healthy skin, the diffusion of subcutaneously injected biotin (green) is restricted by the tight junctions 
of the granular layer (marked by occludin staining in red). Epidermal deletion of, for example, E-cadherin, disturbs epidermal tight junction function as 
shown by penetration of biotin through the tight junction layer. Reprinted from Tunggal et al. (2005); copyright 2005 by John Wiley and Sons. (b) Schematic 
representation of paracellular biotin diffusion through the epidermal barrier in healthy versus disturbed condition.
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tions are mounted in mounting medium and analyzed with a 
fluorescence microscope to determine whether TJs are pres-
ent at intercellular contacts in the granular layer and wheth-
er biotin has penetrated past these TJs.
Alternative molecules, such as fluorescent-labeled dex-
trans of different sizes, may be used in this assay to test 
whether the size-dependent diffusion barrier properties of 
the TJs are changed in the transgenic mouse of interest. A 
potential pitfall is the occasional nonspecific binding of the 
fluorescent-labeled streptavidin to SC structures, which are 
generally prone to unspecific binding in fluorescence anal-
ysis, resulting in a potential false interpretation that sug-
gests leakage of TJs. Therefore, to avoid misinterpretation 
of the assay, a sufficient number of sections and number of 
mice must be analyzed.
OUTSIDE-IN STRATUM CORNEUM BARRIER ASSAY: 
TOLUIDINE BLUE
The SC barrier can be assessed by applying different dyes 
from the outside and measuring how far these dyes pene-
trate into the epidermis. One of the most commonly used 
dyes is toluidine blue, which is a thiazine metachromatic 
dye exhibiting high affinity for acidic tissue components 
and, therefore, nuclear material. It was first discovered in 
1856 by William Henry Perkin and used in the dye industry. 
Since then it has been used in a number of medical appli-
cations, including its initial use as a diagnostic tool in oral 
cancer. Hardman et al. (1998) first described the use of tolu-
idine blue in investigation of skin barrier dysfunction. It was 
shown that toluidine blue penetrance into the epidermis is 
inhibited as the SC epidermal barrier starts to form between 
days 16 and 17 of gestation. Using this assay at different 
time points during development, they demonstrated that 
barrier function spreads dorsally to ventrally and is complete 
at embryonic day 18.5 (Hardman et al., 1998).
To perform the toluidine blue assay, mouse embryos are 
sacrificed and rinsed in PBS followed by immersion in 25, 
50, 75, 100, 75, 50, and 25% methanol to allow toluidine 
blue penetration. Although the mechanism of methanol treat-
ment is not fully understood, it likely involves extraction of 
polar lipids. Subsequently, embryos are rehydrated in PBS 
and immersed in 0.1% toluidine blue for 10 minutes and 
washed again in PBS. The SC barrier function is evaluated 
based on the degree of dye penetration. Embryos with SC 
barrier defects will be stained blue, whereas a functional bar-
rier will prevent staining (Figure 2).
Alternative dyes used for penetration assays to analyze 
the outside-in barrier are X-gal and Lucifer yellow, which 
are both applied to untreated skin. These dyes can only be 
visualized by staining and thus require processing of the 
tissue. The advantage of using toluidine blue is the imme-
diate readout without any further processing. However, 
it does not offer the possibility of being combined with 
immunofluorescence analysis of markers of the barrier. 
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Figure 2.  Outside-in barrier: toluidine blue barrier penetration assay. (a) Toluidine blue staining of 16.5-day-old embryos shows dye penetration at the ventral 
but not the dorsal side, where the barrier already has been formed (left). In mice, the first signs of a functional stratum corneum barrier appear at embryonic 
day 16.5 (E16.5) at the dorsal side of the embryo and progress toward the ventral side, with completion at E18.5. Mouse embryos deficient for loricrin show 
a clear delay in the formation of the stratum corneum barrier, as shown by whole-body penetration of toluidine blue at E16.5 (right, −/−). (b) Schematic 
representation of toluidine blue penetration through the stratum corneum barrier. Modified from Koch et al. (2000).
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The use of these penetration assays is magnified in the case 
of a significantly disrupted barrier (Sevilla et al., 2013; 
Sugawara et al., 2013).
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A PowerPoint slide presentation appropriate for journal club or other teaching 
exercises is available at http://dx.doi.org/10.1038/jid.2014.495.
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1.   Which are the principal structures participating in 
the epidermal barrier?
 A. Tight junctions.
 B. Stratum corneum.
 C. Basement membrane.
 D. Stratum spinosum.
2.  Which are the essential components of the stratum 
corneum barrier?
 A. Protein–lipid crosslinks.
 B. Collagen.
 C. Adherens junctions.
3. Dye penetration assays show which of the following?
 A. The origin of the barrier leakage.
 B. Leakage of the tested barrier.
 C. Severity of barrier defects.
4.  What are the limitations of dye penetration assays?
 A. They cannot show leakiness of a specific barrier.
 B.  Dye penetration may not reflect physiological 
leakiness.
 C.  Single assays are not sufficient to determine the 
origin of the barrier defect.
5. What is the function of the tight junction barrier?
 A. Mechanical rigidity.
 B. Paracellular diffusion barrier.
 C. Separating tissues from outside environment.
 D. Protection from UV light.
QUESTIONS
This article has been approved for 1 hour of Category 1 CME credit.  
To take the quiz, with or without CME credit, follow the link under  
the “CME ACCREDITATION” heading.
For each question, more than one answer may be correct.
